R etinoic acid (RA) treatment of immortalized human retinoblastoma cells Weri-Rb-1 and Y79 dramatically induces the mRNA and protein expression of a cone-specific gene, cone arrestin (CAR), but not its rod-specific counterpart, rod arrestin.
1,2 Because of our interest in the visual developmental pathway, especially cone photoreceptors, and the limited availability of human tissue, the retinoblastoma cell lines were used as an in vitro model system for studying photoreceptor-specific gene regulation. 2 RA induces the specific expression of CAR in this cell line and regulates numerous pathways involved in the differentiation of other cell types. What effect does RA have on cell fate when the differentiation pathway is triggered in these immortalized retinoblastoma cells?
With the advent of DNA microarray technology, the simultaneous study of global gene expression patterns of human retinal genes is feasible. Also, these new advances provide an efficient means of gaining critical insights into the expression, regulation, and potential function of genes that may contribute to human photoreceptor development, for which information is not currently available. To this end, we used commercially prepared microarrays (huGene FL; Affymetrix, Santa Clara, CA) to examine the expression of 6800 known genes in Weri-Rb-1 retinoblastoma cells and their RA-induced, differentiated progeny. These gene expression profiles are highly reproducible and represent modifications of a variety of molecular markers, including genes involved in phototransduction pathways; those expressing transcription factors, growth factors and their receptors, and cytokines and their receptors; and those serving as intracellular signal-transduction modulators and effectors. Our investigation was focused on the rod and cone photoreceptor-specific genes and the evaluation of the parameters of cell cycle, differentiation, and apoptosis of Weri-Rb-1 cells treated with RA. Moreover, our attention was also concentrated on the potential role of retina-specific transcription factors in the developmental cell fate when treated with RA.
MATERIALS AND METHODS

Cell Culture and Treatment
Weri-Rb-1 and Y79 retinoblastoma cells (American Type Culture Collection, Rockville, MD) were maintained and treated with either alltrans RA (ATRA) or the drug vehicle dimethyl sulfoxide (DMSO), as previously described. 2 
Microarray Probe Preparation, Hybridization, and Scan
used for the production of hybridizable biotin-labeled RNA targets by in vitro transcription from T7 RNA polymerase promoters. The cDNA prepared from total RNA was used as a template in the presence of a mixture of unlabeled ATP, CTP, GTP, and UTP and biotinylated CTP and UTP. In vitro transcription products were purified (RNeasy Mini Kit; Qiagen, Valencia, CA) to remove unincorporated NTPs and fragmented by incubation at 94°C for 35 minutes. The fragmented sample cRNA (complementary RNA) was stored at Ϫ20°C until the hybridization was performed.
The following steps were then performed at the Children's Hospital LA Microarray Core Facilities. Gene microarray chips (huGene FL GeneChips; Affymetrix) containing 6800 genes were used to profile mRNA expression. The biotinylated cRNA (10 g/chip) was hybridized for 16 hours at 40°C to a set of oligonucleotide arrays in a hybridization system (GeneChip Fluidics Station 400; Affymetrix). After hybridization, the microarray underwent a series of stringency washes and was stained with streptavidin-conjugated phycoerythrin. Probe arrays were scanned with a confocal laser scanner (Affymetrix).
Data Analysis
Hybridization data from text files were imported to a spreadsheet (Excel; Microsoft, Redmond, WA). Data analysis was performed with software developed by the microarray manufacturer (Genechip Analysis; Affymetrix) and the multiples of change between the hybridization intensities of RA-treated and control samples were obtained.
Real-Time PCR
Three micrograms of total RNA from Weri-Rb-1 cells treated with either 10 M of ATRA or DMSO (control) for 48 hours or 7 days were reverse transcribed with 200 U reverse transcriptase (Superscript II RNase H Ϫ ;
Invitrogen, San Diego, CA) in a volume of 20 L, with 100 M random primers (Invitrogen) used according to the manufacturers' instructions. The quantification of the selected 15 genes by real-time PCR was performed on a fluorescence detection system (LightCycler; Roche Molecular Biochemicals, Mannheim, Germany). Oligonucleotide primers were designed using the accompanying software (LightCycler Probe Design Software; Roche Molecular Biochemicals). The nucleotide sequences of the primers used are shown in Table 1 . The optimal PCR reactions for all investigated genes were established with a kit (LightCycler Fast Start DNA Master SYBR Green I Kit; Roche Molecular Biochemicals), according to the manufacturer's instructions. Annealing temperatures and MgCl 2 concentrations were optimized to create a one-peak melting curve. In addition, the PCR reactions were recovered after each PCR analysis and amplicons were checked by agarose gel electrophoresis for a single band of the expected size. Real-time PCR mix was prepared as follows (to the indicated end-
, and 2 L of master mix from the kit (LightCycler-Fast Start DNA Master SYBR Green I; Roche Molecular Biochemicals). Nineteen microliters of the PCR mix was placed in the glass capillaries and a 1 L volume of cDNA was added as a PCR template. Capillaries were closed, centrifuged, and placed into a cycling rotor. A four-step experimental run protocol was used: a denaturation program (10 minutes at 95°C), an amplification and quantification program repeated 40 times (15 seconds at 95°C, 45 seconds at 55°C or at 57°C for some genes, 60 seconds at 72°C, with a single fluorescence measurement), a melting curve program (45°C for 30 seconds with a continuous fluorescence measurement), and a cooling program down to 40°C.
The reaction product was characterized by the point during cycling when amplification of PCR products was first detected (crossing point) with the manufacturer-provided software (LightCycler, ver. 3.5; Roche Molecular Biochemicals). The results are presented as the ratios of mRNA expression in treated cells in relation to the amount present in untreated cells and are normalized to an internal control gene, ␤-actin, for different mRNA input and reverse transcript efficiencies.
Northern Blot Analysis
Northern blot analysis was performed as previously described. 1, 2 Probes used for hybridizations were prepared by RT-PCR with RAtreated or untreated Weri-Rb-1 cell cDNA as a template and verified by DNA sequencing.
Immunoblot Analysis
Immunoblot analysis was performed as described. 2 The immobilized proteins were detected on the membrane with an enhanced chemiluminescence kit with affinity-purified anti-bovine CRX peptide polyclonal antibody 3 or anti-human thyroid hormone receptor (TR)-␤2 (N-16) peptide goat polyclonal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) at 1: 1000 and 1:100 dilutions, respectively. Anti-rabbit (Bio-Rad Laboratories, Richmond, CA) or anti-goat (Santa Cruz Biotechnology) secondary antibodies were used at 1:10,000 and 1:5,000 dilutions.
Determination of Cell Cycle Stage by Fluorescence-Activated Cell Sorting
Cellular DNA content was analyzed with a flow cytometry system (FACScan; BD Bioscience Immunocytometry Systems, San Jose, CA) at the Norris Cancer Center Core Flow Cytometry Facility of the Keck School of Medicine of the University of Southern California (USC). Briefly, treated or untreated Weri-Rb-1 cells were harvested and washed, fixed in cool 70% ethanol for at least 2 hours, and then incubated with 1 mL propidium iodide/Triton X-100 staining solution 
Immunocytochemistry
Weri-Rb-1 cells from suspension culture were gently dissociated and plated onto poly-D-lysine eight-well chamber slides (Cellware; BD Bioscience) at 3 ϫ 10 5 cells/mL and maintained for 24 hours before the addition of RA (10 M) or DMSO. Medium was changed and chemicals were reapplied every 2 days. After treatment for 5 days, medium was removed, and the cells were processed for immunofluorescent staining with the affinity-purified anti-hCAR polyclonal peptide antibody LUMIF, 1 and a Cy3-conjugated goat anti-rabbit secondary antibody, as described. 3 The slides were mounted and photographed with a confocal microscope (Carl Zeiss, Inc., Oberkochen, Germany). 
Analysis of Apoptosis
To detect apoptosis in individual cells, Weri-Rb-1 cells were seeded onto poly-D-lysine eight-well chamber slides and treated as described earlier in the immunocytochemistry study. After a 48-hour treatment with either RA or DMSO, cells were fixed in 4% paraformaldehyde in PBS for 25 minutes at 4°C, rinsed with PBS and permeabilized for 5 minutes on ice in 0.2% Triton X-100 in PBS. Apoptotic cells were visualized by means of the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay, 4 with an apoptosis detection system (Apoptosis Detection System; Promega), according to the manufacturer's instructions. After labeling with fluorescein-12-dUTP, the slides were rinsed with 2ϫ SSC, and propidium iodide (PI) was added to stain all cells. The slides were then mounted and photographed. Apoptotic cells were quantified by counting cells labeled with fluorescein-12-dUTP in 10 random fields per condition under a microscope. The total number of apoptotic cells was divided by the total number of cells stained with propidium iodide in the same field, yielding the percentage of apoptotic cells within each specified field.
RESULTS
RA Induction of Global Transcriptional Profile Changes in Weri-Rb-1 Cells
To determine whether induction of cone arrestin by RA treatment is accompanied by transcriptional alterations of other visual transduction genes in retinoblastoma cells, we conducted studies using oligonucleotide array technologies (Affymetrix) to monitor gene expression changes in Weri-Rb-1 cells treated with either ATRA or DMSO (control). To ensure reproducibility of the microarray results, each experiment was repeated twice. Genes that were either up-or downregulated were defined as those signals that showed at least a twofold difference between RA-and DMSO-treated cells. [5] [6] [7] In a total of 6800 genes examined, with the 3-hour treatment only 55 were upregulated and 17 were downregulated. With the 48-hour treatment, 506 genes were upregulated and 552 genes were downregulated, and with the 7-day treatment 310 genes were upregulated and 154 were downregulated. A complete list of these up-and downregulated genes is available on our Web site (http://eyesightresearch.org). Representative up-and downregulated genes are shown in Tables 2 and 3 , respectively, with their GenBank accession numbers (http://www.ncbi.nlm.nih. gov/Genbank; GenBank is provided in the public domain by the National Center for Biotechnology Information, Bethesda, MD).
RA stimulated numerous cone-specific genes, not only cone arrestin, but also genes for cone phosphodiesterase (PDE)-␣ subunit, green cone pigment gene, and cone transducin alpha subunit, after either 48 hours or 7 days of treatment. Guanylyl cyclase-activating protein (GCAP)-1, which has a higher expression level in cones than in rods, 8 increased by 2.2-fold after 3 hours of RA treatment and continued to increase with longer treatment. TR␤2, which is essential in the development of green cone photoreceptors, 9 increased by 7.2-fold after 48 hours, but decreased 5-fold after 7 days of RA treatment. The retinoic acid receptor (RXR)-␥ was upregulated after both 48 hours (3.3-fold) and 7 days (2.8-fold) of RA treatment. Expression of chicken ovalbumin upstream promoter-transcription factors (COUP-TF1) increased 4.4-, 16.2-, and 13.6-fold after 3 hours, 48 hours, and 7 days of RA treatment, respectively.
A dramatic contrast was observed in visual genes associated with components of the rod phototransduction pathway. All three subunits of rod transducin (␣, ␤, and ␥) and the rod photoreceptor cGMP-gated channel were each downregulated significantly, as shown in Table 3 . Cone rhodopsin-sensitive cGMP 3Ј5Ј-cyclic phosphodiesterase gamma subunit (PDE6H), which is expressed in blue cone photoreceptor cells, was also among those downregulated genes. Adenylyl cyclase type II was downregulated dramatically after both 48 hours (55.1-fold) and 7 days (71.5-fold) of RA treatment. It is notable that transducin-like enhancer protein-1, a human protein homologous to Drosophila groucho (Gro) that affects neuronal fate through negative regulation of gene expression, 10,11 decreased 2.2-, 30-, and 4.9-fold after a 3 hours, 48 hours, and 7 days of RA treatment, respectively. Major histocompatibility complex (MHC) class I, previously identified in differentiated Y79 cells after RA treatment 12 and essential in central nervous system development, 13 increased 2.9-fold after 3 hours and 6.2-fold after 48 hours.
Another prominent observation of our study is that numerous cell cycle regulatory proteins, including cyclins, cyclindependent kinases (cdks), cdk inhibitors (CKIs), and the E2F families of proteins, which constitute a network of interacting factors that govern exit from or passage through the mammalian cell cycle, were downregulated by RA treatment, whereas the retinoblastoma (Rb) family members Rb1 and Rb-related protein p107 were upregulated after 48 hours of RA treatment. In contrast, the DNA fragmentation factor-45 ␣-subunit and caspase 8, which are coupled with apoptosis, 14, 15 were increased 17.6-fold and 3.2-fold, respectively, after 48 hours.
Rb is a tumor suppressor involved in the transcriptional regulation of genes required for the G 1 -to-S phase transition of the cell cycle, 16 and the mutation of this gene is the cause of hereditary retinoblastomas. 17 Whereas all normal tissues and many tumor cells express an Rb mRNA of 4.7 kb, retinoblastomas were found either to have no Rb expression or to have Rb transcripts of reduced size (4.0 kb). 17 Weri-Rb-1 has a homozygous deletion of the entire Rb gene, whereas Y79 contains a partial deletion of one allele and an uncharacterized mutation in the other. 18 -20 In our experimental system, the upregulated Rb mRNA in Weri-Rb-1 cells by RA treatment is most likely a cross reaction with other Rb-related genes that are upregulated by RA.
Validation of Array Results by Real-Time PCR
Eleven genes with significant expression changes by microarray analysis, including those expressed in either cone or rod photoreceptors, were selected for confirmation of their relative expression by real-time quantitative PCR. Because of the importance of photoreceptor-specific transcription factors in the regulation of rod and cone photoreceptor differentiation, we also determined the relative change in expression of CRX, a homeobox gene 3, 21, 22 ; OTX2, another member of the homeodomain-containing transcription factors, which is highly homologous to CRX and expressed in brain and retina [23] [24] [25] ; 26 -29 ; and NR2E3, a photoreceptor-specific nuclear receptor. 30 -32 The quality of the realtime PCR products is shown in Figure 1 , and the relative multiples of change in expression of these genes as determined by microarray, real-time PCR, and Northern blot analyses are presented in Table 4 .
The overall concordance of trends between the two techniques was 77% (e.g., an increase or decrease in gene expression seen by microarray in 48 hours and 7 days compared with real-time PCR). For those genes with results that agreed between the two experiments, 71% of these results indicated larger change multiples by real-time PCR than those identified by array analysis. This concordance includes both genes determined to be significantly changed and those genes determined not to have significantly changed. CRX was slightly upregulated after both 48 and 72 hours of RA treatment, which is consistent with the results of Northern blot analysis (Table 4 and later discussion). However, the expression of OTX2, NRL, and NR2E3 did not change after RA treatment of the Weri-Rb-1 cells, as shown by real-time quantitative PCR (Table 4) .
Confirmation of CRX and TR␤2 Upregulation by RA
CRX is a homeobox gene specifically expressed in the photoreceptors of the developing and mature retina and is crucial in rod and cone photoreceptor differentiation. 21, 22 Previously, we identified potential CRX elements in the cone arrestin promoter. 2, 34 Because the microarrays (huGene FL; Affymetrix) did not contain the CRX gene, Northern blot analysis was used to examine CRX gene regulation by RA in Weri-Rb-1 and Y79 cells. A CRX-specific cDNA fragment, which is outside the homeodomain, was radioactively labeled and used as a probe for Northern blot analysis. As shown in Figure 2A , the expression of both the 3.9-and the 2.5-kb mRNA of CRX was induced dramatically by 6-day RA treatment in both cell types. To analyze the dynamics of this induction, a dose-response and time-course analysis of CRX mRNA expression was analyzed after RA treatment of Weri-Rb-1 cells. Figure 2B shows that RA enhanced CRX mRNA levels in a dose-dependent manner and that the maximal effect was achieved with 3 M RA. In the time-course experiments, the expression of CRX mRNA was elevated above basal levels after 4 days of exposure to RA (Fig. 2C) . Immunoblot analysis confirmed that the immunoreactive CRX protein was upregulated after 6 days of RA treatment (Fig. 2D) . Immunoreactive NRL, a rod-specific transcription factor, was below detectable levels in these cells, whether To further confirm the gene regulation of TR␤2 by RA observed by the microarray analysis, both Northern and immunoblot blot analyses were performed. Northern blot from the CRX time-course experiment was reprobed with a TR␤2 cDNA probe, which revealed multiple human TR␤2 mRNAs of 2.4, 2.5, 5.2, and 6.6 kb in Weri-Rb-1 cells. The expression of TR␤2 mRNA slightly decreased during the initial 12 hours, but increased above basal levels after 24 hours of RA treatment. It reached its maximum induction of 1.7-fold over the control by 5 days (120 hours) and thereafter decreased (Figs. 3A, 3B ). Immunoblot analysis of the TR␤2 protein from this experiment determined a single band of 60 kDa in Weri-Rb-1 cells. TR␤2 protein levels increased after 4 days of RA treatment and remained constant until day 8 (Fig. 3C) .
RA Induction of G 0 /G 1 Cell Cycle Arrest
To verify the microarray observation that RA inhibits cell cycle progression, flow cytometry analysis determined the cell cycle phases. Representative examples depicting the effect of RA treatment on distribution of the cell cycle phases in the retinoblastoma cell line are shown in 
RA Induction of CAR-Immunoreactive Staining in Weri-Rb-1 Cells
Previously, we have shown by using immunoblot analysis that RA upregulates CAR protein levels in both Weri-Rb-1 and Y79 cells. 1, 2 To further examine the CAR protein expression pattern in RA-treated Weri-Rb-1 cells, we performed an immunocytochemical study. In related work, CAR has been identified in all cone photoreceptor cells and thus is an excellent hallmark for cones. 1 As shown in Figure 5 , treatment of Weri-Rb-1 cells with 10 M of RA for 5 days increased the staining intensity with a CAR-specific antibody compared with the control (DMSO-treated) cells, suggesting that RA induces the subset of retinoblastoma cells to differentiate toward cone cell lineage.
RA Induction of Apoptosis in a Subpopulation of Retinoblastoma Cells
The effect of RA on apoptosis in Weri-Rb-1 cells was also analyzed by TUNEL assay. As shown in Figure 6 , the percentage of apoptotic cells increased in RA-treated cultures by 48 hours, compared with DMSO-treated control groups. An average of 16% of apoptotic cells was observed in control groups, in contrast to 35% in RA-treated cultures (P Ͻ 0.05; unpaired t-test; n ϭ 3). These cumulative data, together with the immunocytochemical data, suggest that both an increase in conelike cells and a decrease in other cellular subtypes by apoptosis play a role during RA treatment, resulting in a net increase or decrease in the expression level of cone-and rod-specific visual pathway genes, respectively.
DISCUSSION
For many years, the vitamin A metabolite RA has been known to have profound effects on development, cellular proliferation and differentiation, and tumor growth and invasion. RA is known to play an important role during embryonic development in the generation of several organs and systems, including the retina in the eye [35] [36] [37] [38] [39] [40] [41] [42] and the nervous system. [43] [44] [45] In vitro, RA also plays a prominent role in regulating the transition from the proliferating precursor cell to the postmitotic differentiated cell. 46, 47 The wide-ranging effects of RA on cellular proliferation and migration have made it a useful chemotherapeutic agent in the treatment of many types of cancer.
In prior work, we examined the molecular mechanisms involving both the mRNA transcription and the protein translation of cone arrestin expression that are dramatically in- creased with RA treatment of retinoblastoma cells. 2 Because RA induces hCAR expression in retinoblastoma cells through the upregulation of RXR␥, which is mainly localized to the cone photoreceptors in the human retina, it would be interesting to know whether RA induction of hCAR is accompanied by transcription alterations of other cone-specific genes. With oligonucleotide array-based expression-profiling technology (Affymetrix), we observed that the expression pattern of a broad network of genes was modulated in a time-dependent manner by RA treatment. In addition, with RA treatment, the retinoblastoma cell line underwent G 0 /G 1 cell cycle arrest and displayed conelike genetic differentiation and selective apoptosis.
Cell differentiation is a coordinated process that includes cell cycle exit and tissue-specific gene expression. 48 The present study is of particular interest and significance because RA upregulated a subset of cone-specific genes during the differentiation of retinoblastoma cells. These results are consistent with the established concept that RA levels influence cell fate and mediate the differentiation of specific neuronal phenotypes during retinal histogenesis. 38, 49 In cultured embryonic rat or fetal human retinas, RA promotes retinal progenitor cells to develop into rod photoreceptors. 39 Exogenous RA also promotes rod photoreceptor differentiation in rat retina in vivo when injected in pregnant rats at days 18 and 20 of gestation. 39 Moreover, application of RA to zebrafish embryos causes precocious rod photoreceptor development and inhibition of the maturation of cone photoreceptors. 50 The results presented in this article are in conflict with the published observations, in that RA induced retinoblastoma cells to differentiate into cone photoreceptors, but it inhibited rod gene expression. This discrepancy could be explained in at least three ways. First, the effect of RA on cell differentiation during embryonic development is probably tightly controlled by timing. All the published results have been obtained with embryonic retinas, but the retinoblastoma cell lines were developed from juvenile tumor tissues, which had passed the embryonic developmental stage. Indeed, a more recent observation reveals that RA induces rod photoreceptor-selective apoptosis during postnatal development of mouse retina. 51 Second, the retinoblastoma cells used in our study may differ from developing retinal cells in that certain diffusible induction factors normally found in the microenvironment of the embryo may be either missing or present in overabundance. A third alternative is the different cell-cell interaction involved in the RA-induced cell differentiation between normal retinal development and retinoblastoma cell differentiation. In normal retinal development, photoreceptors arise from a population of precursor cells that are multipotent and intrinsic in the retina. The first photoreceptors to form are the cones, with the rods appearing much later. However, in retinoblastoma, neoplastic photoreceptors, mostly red/green-sensitive cones, and glia cells (Müller cells) constitute the overwhelming majority of the cells. 53 It seems likely that RA induces retinoblastoma cells along a red/greencone pathway due to a red/green-cone-dominant microenvironment.
We have also shown that RA downregulates rod-specific genes during retinoblastoma cell differentiation. Given the example that RA induces rod-selective apoptosis during postnatal retinal development, 51 it easily led us to postulate that RA also induces the rodlike cell population in the heterogeneous retinoblastoma cell line to choose a cell death pathway. This assumption is supported by the increased expression of a DNA fragmentation factor, caspase 8, and the increased number of apoptotic cells in RA-treated Weri-Rb-1 cells compared with the DMSO-treated control.
Microarray analysis also revealed that RA treatment of WeriRb-1 cells resulted in an induction of expression of genes in the steroid-thyroid receptor superfamily, such as RXR␥, TR␤2, and COUP-TF1, plus a photoreceptor-specific homeobox gene, CRX. Previously, we identified that both Weri-Rb-1 and Y79 cells express all subtypes of RAR and RXR transcripts, and RXR␥ is potentially the RA receptor subtype involved in human cone arrestin regulation by RA.
2
TR␤2 is a member of the steroid-thyroid receptor superfamily that plays a key role in cone-specific gene expression. Thyroid hormone receptors are located in the developing chicken retina 54, 55 with the TR␤2 isoform being expressed in cones. 54 Northern blot analysis revealed a prominent expression of TR␤2 mRNA in mouse eye development, which peaked at approximately embryonic day 17.5 and declined in the postnatal period, similar to the pattern in chick. 9 In recent mouse gene-knockout studies, deleting the THRB gene (encoding TR␤2) caused the selective loss of green (M) cones and a concomitant increase in S-opsin immunoreactive cones. 9 Our microarray and Northern blot data are consistent with this study, because the upregulation of TR␤2 is followed by the increase in expression of green cone pigment gene after RA treatment. Furthermore, the human cone arrestin promoter also contains an element (DR-4) that strongly resembles an authentic thyroid hormone response element (TRE). 2 These results suggest that TR␤2 may play an important role in driving cone-specific gene expression, both in developing retina and in retinoblastoma differentiation.
Several studies have suggested that COUP-TF may be a part of the retinoid signaling pathway, both in vivo and in cell culture systems. 56 -58 Upregulation of COUP-TFI and COUP-TFII genes also occurs in differentiation programs of P19 embryonic carcinoma (EC) cells triggered by retinoic acid (RA). 59 The biological importance of COUP-TF in retina development was demonstrated with the Drosophila homologue seven-up (SVP). SVP is essential to specify photoreceptor subtype in the development of the compound eye. 60, 61 Lu et al. 62 further demonstrated that in the mouse, bovine, or human rod arrestin gene promoter, a DR-7 element (TGACCT of direct repeat with a 7-bp spacer), mediates the positive transcriptional effect of COUP-TF. The mouse retinal expression pattern of COUP-TF in embryonic day 14 coincided with the initial expression of the rod arrestin gene. No COUP-TF transcripts were detected in either adult retina or Weri-Rb-1 cells, 62 leading them to propose that COUP-TF may effectively regulate only the expression of the rod arrestin gene in the developing retina, whereas other factors regulate this gene in the adult retina and in retinoblastoma cells. 62 We demonstrated for the first time that RA rapidly induces expression of COUP-TF1 in Weri-Rb-1 cells, and the expression of COUP-TF1 is associated with retinoblastoma cell differentiation, implying that COUP-TF1 plays a crucial role, not only in the control and timing of rod-specific programs during retinal development, but also in cone-specific programs during the differentiation of cone photoreceptors.
CRX is the first major photoreceptor-specific homeodomain transcription factor to be identified. 21, 22, 63 Although CRX is unlikely to be the dominant transcription factor involved in expression of the cone arrestin and cone transducin alpha subunit (GNAT2) genes, despite the presence of three CRX binding sites in the cone arrestin promoter, 2 we could not exclude the green cone pigment gene from transactivation by CRX, because it was expressed only after 7 days of RA treatment in Weri-Rb-1 and was absent in CRX Ϫ/Ϫ mice. 64 The requirement for CRX in transcription of the cone opsin loci in mice supports the notion that the human red/green locus requires CRX activity at the CRX-binding element in the locus control region. 22 In summary, our findings imply that RA mediates induction that coordinates cone-specific gene activation, rod-specific gene inactivation, and cell cycle arrest during the differentiation of retinoblastoma cells. The molecular events involved depend on the modulation of two main opposing switches that contain members of the steroid-thyroid receptor superfamily and cell cycle regulators. This may represent a general mechanism by which retinoids signal cell cycle control and cell fate biases that may have therapeutic implications in the pharmacologic triggering of growth suppression and destruction of tumor cells. Even more important, the fact that RA induces most of these cells to differentiate into a more conelike phenotype may someday be part of a viable option for therapeutic rescue of the cone photoreceptors before their destruction leads to blindness. 
